Other Relevant Evidence: The European Increlex Growth Forum Database Registry Description of Study The European Increlex Growth Forum Database (EU-IGFD) Registry 20 - 22 is a descriptive, multi-centre, observational, prospective, open-ended, noninterventional, post-authorization safety surveillance study of mecasermin
Growth hormone has potent lipolytic effects on adipose tissue through direct mechanisms independent of IGF-1
The bridge between those two "NAC's antioxidant activity, applied to a population with elevated oxidative load, produces clinically meaningful improvements" is the part where you are extrapolating rather than citing a definitive trial
The pathologic effects of large amounts of glucagon
JACC 65(20):21592169 Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P (2017) Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise